Abstract:Objectives: To investigate the efficacy and safety of CS1002, an over-the-counter cough treatment containing diphenhydramine, ammonium chloride and levomenthol in a cocoa-based demulcent. Design: A multicentre, randomised, parallel group, controlled, single-blinded study in participants with acute upper respiratory tract infection-associated cough. Setting: 4 general practitioner (GP) surgeries and 14 pharmacies in the UK. Participants: Participants aged ≥18 years who self-referred to a GP or pharmacist with acute cough of <7 days' duration. Participant inclusion criterion was cough severity ≥60 mm on a 0-100 mm visual analogue scale (VAS). Exclusion criteria included current smokers or history of smoking within the past 12 months (including e-cigarettes). 163 participants were randomised to the study (mean participant age 38 years, 57% females). Interventions: Participants were randomised to CS1002 (Unicough) or simple linctus (SL), a widely used cough treatment, and treatment duration was 7 days or until resolution of cough. Main outcome measures: The primary analysis was intention-to-treat (157 participants) and comprised cough severity assessed using a VAS after 3 days' treatment (prespecified primary end point at day 4). Cough frequency, sleep disruption, health status (Leicester Cough Questionnaire (LCQ-acute)) and cough resolution were also assessed. Results: At day 4 (primary end point), the adjusted mean difference (95% CI) in cough severity VAS between CS1002 and SL was -5.9 mm (-14.4 to 2.7), p=0.18. At the end of the study (day 7) the mean difference in cough severity VAS was -4.2 mm (-12.2 to 3.9), p=0.31. CS1002 was associated with a greater reduction in cough sleep disruption (mean difference -11.6 mm (-20.6 to 2.7), p=0.01) and cough frequency (mean difference -8.1 mm (-16.2 to 0.1), p=0.05) compared with SL. There was greater improvement in LCQ-acute quality of life scores with CS1002 compared with SL: mean difference (95% CI) 1.2 (0.05 to 2.36), p=0.04 after 5 days' treatment. More participants prematurely stopped treatment due to cough improvement in the CS1002 group (24.4%) compared with SL (10.7%; p=0.02). Adverse events (AEs) were comparable between CS1002 (20.5%) and SL (27.6%) and largely related to the study indication. 6 participants (7%) in the CS1002 group reduced the dose of medication due to drowsiness/tiredness, which subsequently resolved. These events were not reported by participants as AEs. Conclusions: Although the primary end point was not achieved, CS1002 was associated with greater reductions in cough frequency, sleep disruption and improved health status compared with SL. Trial registration number: EudraCT number 2014-004255-31.

Efficacy and Safety of Dextromethorphan-Chlorpheniramine-pseudoephedrine Solution in Treating Cough Caused by Acute Upper Respiratory Tract Infections in 133 Patients

New Strategy for Cough Treatment-Comparison Effect and Safety of Cofetol Cough Syrup with Dextromethorphan Hydrobromide, Chorpheniramine Mateate and Pseudoe Phedrine Hydiochloride Solution in the Treatment of Acute Cough

Clinical study on the efficacy and safety of Dextromethorphan Hydrochloride, Chlorphenamine Malente, and Ammonium Chloride Syrup on eliminating or relieving the symptoms of acute upper respiratory infection in children

Efficacy and Safety of Guaifenesin-Pseudoephedrine Hydrochloride-Codeine Phosphate Oral Solution

Effect and Safety of Pseudoephedrine-Dextromethorphan Drops

A Controlled Study on Ibuprofen Pseudoephedrine Hydrochloride and Chlorpheniramine Maleate Tablets and Paracetamol Pseudoephedrine Hydrochloride and Chlorphenamine Maleate Tablets in the Treatment of Upper Respiratory Tract Infection

Efficacy of Sequential Three-Step Empirical Therapy for Chronic Cough.

A Prospective Multicenter Randomized Controlled Study on the Efficacy and Safety of Jin-Zheng Oral Solution

Efficacy and Safety of Modified Sequential Three-Step Empirical Therapy for Chronic Cough

Comparison of Efficacy of Sequential Empirical Three-Step Therapy for Chronic Cough among Different Grades of Hospitals

A multicenter study to evaluate the efficacy and safety of compound methoxyphenamine in the treatment of postinfectious cough

A phase Ⅲ clinical trial of ibuprofen, pseudoephedrine hydrochloride and chlorphenamine maleate tablets in treatment of adult cold

Comparison Effect and Safety of Cofetol Cough Syrup with Compound Codeine Syrup in the Treatment of Infections of Respiratory Tract

Pharmacokinetics of Dextromethorphan and Its Metabolite in Chinese Healthy Volunteers after a Single Oral Dose of Compound Anti- Cough Agent

Evaluation of clinical curative effect and safety of dimemorfan phosphate in the treatment of dry cough

Empiric Treatment of Chronic Cough in Adults

Clinical benefit of sequential three-step empirical therapy in the management of chronic cough.

Ambroxol hydrochloride spray (Luo Runchang®) in the treatment of acute respiratory infectious diseases: a prospective, multicenter, open label, randomized controlled study

A Phase Ⅱ Clinical Trial for Compound Codeine Phosphate Tablets in Treatment of Moderate or Severe Cough

Efficacy and Safety of Roxithromycin/ambroxol Dispersible Tablets in Patients with Acute Bacterial Lower Respiratory Tract Infection

Rococo study: a real-world evaluation of an over-the-counter medicine in acute cough (a multicentre, randomised, controlled study)